These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 16035311)
1. [Drug-induced diabetes mellitus: the exemple of atypical antipsychotics]. Scheen AJ; De Hert M Rev Med Liege; 2005; 60(5-6):455-60. PubMed ID: 16035311 [TBL] [Abstract][Full Text] [Related]
2. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. Newcomer JW CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156 [TBL] [Abstract][Full Text] [Related]
4. Abnormal glucose metabolism in patients treated with antipsychotics. Scheen AJ; De Hert MA Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628 [TBL] [Abstract][Full Text] [Related]
5. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
7. A review of real-world data on the effects of aripiprazole on weight and metabolic outcomes in adults. Citrome L; Kalsekar I; Baker RA; Hebden T Curr Med Res Opin; 2014 Aug; 30(8):1629-41. PubMed ID: 24666104 [TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics: new drugs, new challenges. Mathews M; Muzina DJ Cleve Clin J Med; 2007 Aug; 74(8):597-606. PubMed ID: 17708131 [TBL] [Abstract][Full Text] [Related]
9. Atypical antipsychotics and diabetes mellitus. Lichiardopol R Rom J Intern Med; 2004; 42(2):301-12. PubMed ID: 15529621 [TBL] [Abstract][Full Text] [Related]
10. Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications. Melkersson K; Dahl ML Drugs; 2004; 64(7):701-23. PubMed ID: 15025545 [TBL] [Abstract][Full Text] [Related]
11. [Diabetes and second-generation (atypical) antipsychotics]. Chabroux S; Haffen E; Penfornis A Ann Endocrinol (Paris); 2009 Sep; 70(4):202-10. PubMed ID: 19700142 [TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. Nasrallah HA; Newcomer JW J Clin Psychopharmacol; 2004 Oct; 24(5 Suppl 1):S7-14. PubMed ID: 15356415 [TBL] [Abstract][Full Text] [Related]
13. Relationship of atypical antipsychotics with development of diabetes mellitus. Citrome LL; Jaffe AB Ann Pharmacother; 2003 Dec; 37(12):1849-57. PubMed ID: 14632602 [TBL] [Abstract][Full Text] [Related]
14. [Schizophrenia, diabetes mellitus and antipsychotics]. Gury C Encephale; 2004; 30(4):382-91. PubMed ID: 15538314 [TBL] [Abstract][Full Text] [Related]
15. Side effects of atypical antipsychotic drugs. Ananth J; Parameswaran S; Gunatilake S Curr Pharm Des; 2004; 10(18):2219-29. PubMed ID: 15281897 [TBL] [Abstract][Full Text] [Related]
16. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature. Cohen D Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042 [TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis. Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649 [TBL] [Abstract][Full Text] [Related]
18. Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model. Chintoh AF; Mann SW; Lam L; Giacca A; Fletcher P; Nobrega J; Remington G Schizophr Res; 2009 Mar; 108(1-3):127-33. PubMed ID: 19157785 [TBL] [Abstract][Full Text] [Related]
19. Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone. Manu P; Correll CU; Wampers M; van Winkel R; Yu W; Shiffeldrim D; Kane JM; De Hert M Schizophr Res; 2013 Feb; 143(2-3):358-62. PubMed ID: 23231880 [TBL] [Abstract][Full Text] [Related]
20. Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis. Gentile S Drug Saf; 2006; 29(4):303-19. PubMed ID: 16569080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]